RxDoctor Payments Data

Daniel Hwang, MD

Otolaryngology · Reston, VANPI 1184678856

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,615 of the $3,693 with a category attached, or 70.8%. 13 manufacturers reported payments, led by Medtronic at 35.5% of the total. Reporting peaked in 2020 at $1,234 and has fallen 55.2% since, to $552 in 2025.

$3,693in general payments, 2019–2025

Across 41 payments — averaging $90.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Regeneron Healthcare Solutions, Inc.$562
  • Integra Lifesciences Corporation$363
  • Aerin Medical Inc.$304
  • Gilead$189
  • Stryker$183
  • plus $779 from 7 others

What the payments were for

  • Travel & lodging$1,07829%
  • Food & beverage$2,61571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,693 in reported general payments places this provider in the 75th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$138,060
Medicare patients
642
Services billed
1,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth28$3,085
Azelastine Hcl20$1,414
Fluticasone Propionate85$1,210
Ipratropium Bromide57$1,150
Ofloxacin30$969
Fluocinolone Acetonide Oil18$595
Mupirocin47$379
Methylprednisolone12$93

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Reston

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →